MERCK & CO., INC. (MRK)
Clinical trial NCT03131908 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-12-31 → 2026-08-20 3. primary completion date: 2027-12-31 → 2026-08-20 4. enrollment: 27 → 28 participants
Clinical trial NCT03131908 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-12-31 → 2026-08-20 3. primary completion date: 2027-12-31 → 2026-08-20 4. enrollment: 27 → 28 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical